| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema.
|
N Engl J Med
|
2003
|
10.40
|
|
2
|
DNA methylation markers and early recurrence in stage I lung cancer.
|
N Engl J Med
|
2008
|
5.87
|
|
3
|
Patients at high risk of death after lung-volume-reduction surgery.
|
N Engl J Med
|
2001
|
5.76
|
|
4
|
American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer.
|
J Clin Oncol
|
2009
|
4.95
|
|
5
|
Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
|
J Urol
|
2003
|
4.66
|
|
6
|
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation.
|
N Engl J Med
|
2016
|
3.99
|
|
7
|
Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.
|
Clin Cancer Res
|
2010
|
3.56
|
|
8
|
Hypermethylation of CpG islands in primary and metastatic human prostate cancer.
|
Cancer Res
|
2004
|
3.29
|
|
9
|
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer.
|
J Clin Oncol
|
2011
|
3.21
|
|
10
|
Primary chemoprevention of familial adenomatous polyposis with sulindac.
|
N Engl J Med
|
2002
|
3.16
|
|
11
|
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.
|
Clin Gastroenterol Hepatol
|
2004
|
3.10
|
|
12
|
Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib.
|
Arch Neurol
|
2008
|
2.86
|
|
13
|
Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide.
|
Clin Cancer Res
|
2011
|
2.59
|
|
14
|
A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation.
|
Ann Surg
|
2011
|
2.50
|
|
15
|
Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype.
|
Clin Cancer Res
|
2005
|
2.21
|
|
16
|
Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation.
|
J Clin Oncol
|
2009
|
1.98
|
|
17
|
Phase I clinical and pharmacokinetic study of irinotecan in adults with recurrent malignant glioma.
|
Clin Cancer Res
|
2003
|
1.79
|
|
18
|
Phase II, randomized, placebo-controlled trial of neoadjuvant celecoxib in men with clinically localized prostate cancer: evaluation of drug-specific biomarkers.
|
J Clin Oncol
|
2009
|
1.71
|
|
19
|
Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial.
|
J Natl Cancer Inst
|
2007
|
1.65
|
|
20
|
Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations.
|
Lancet Neurol
|
2012
|
1.54
|
|
21
|
Phase I/II trial of an allogeneic cellular immunotherapy in hormone-naïve prostate cancer.
|
Clin Cancer Res
|
2006
|
1.50
|
|
22
|
Oral valacyclovir as prophylaxis against herpes simplex virus reactivation during high dose chemotherapy for leukemia.
|
Leuk Lymphoma
|
2004
|
1.41
|
|
23
|
Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial.
|
J Clin Oncol
|
2009
|
1.41
|
|
24
|
Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study.
|
Blood
|
2003
|
1.29
|
|
25
|
Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease.
|
J Clin Oncol
|
2007
|
1.27
|
|
26
|
PIG-A mutations in normal hematopoiesis.
|
Blood
|
2005
|
1.27
|
|
27
|
Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
|
J Clin Oncol
|
2005
|
1.02
|
|
28
|
Phase II trial of docetaxel chemotherapy in patients with incurable adenocarcinoma of the esophagus.
|
Invest New Drugs
|
2002
|
1.01
|
|
29
|
Safety and efficacy of median sternotomy versus video-assisted thoracic surgery for lung volume reduction surgery.
|
J Thorac Cardiovasc Surg
|
2004
|
1.00
|
|
30
|
Spatial analyses identify the geographic source of patients at a National Cancer Institute Comprehensive Cancer Center.
|
Clin Cancer Res
|
2010
|
0.97
|
|
31
|
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer.
|
Cochrane Database Syst Rev
|
2015
|
0.96
|
|
32
|
High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement.
|
Biol Blood Marrow Transplant
|
2005
|
0.91
|
|
33
|
Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.
|
PLoS One
|
2013
|
0.91
|
|
34
|
Differentiation therapy in poor risk myeloid malignancies: Results of a dose finding study of the combination bryostatin-1 and GM-CSF.
|
Leuk Res
|
2010
|
0.87
|
|
35
|
Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood.
|
J Hematother Stem Cell Res
|
2002
|
0.84
|
|
36
|
Dose finding with drug combinations in cancer phase I clinical trials using conditional escalation with overdose control.
|
Stat Med
|
2014
|
0.83
|
|
37
|
[American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer].
|
Zhongguo Fei Ai Za Zhi
|
2010
|
0.82
|
|
38
|
Durable molecular remissions with a single cycle of timed sequential consolidation chemotherapy in acute promyelocytic leukemia.
|
Am J Hematol
|
2005
|
0.81
|
|
39
|
Local recurrence after mastectomy in patients with T3pN0 breast carcinoma treated without postoperative radiation therapy.
|
Am J Clin Oncol
|
2007
|
0.81
|
|
40
|
The integrated proactive surveillance system for prostate cancer.
|
Open Med Inform J
|
2012
|
0.79
|
|
41
|
Interferons in relapsing remitting multiple sclerosis.
|
Lancet
|
2003
|
0.78
|
|
42
|
Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas.
|
J Neurooncol
|
2011
|
0.78
|
|
43
|
Proper interpretation and analysis of censored events and studies that contain them.
|
Mult Scler
|
2005
|
0.77
|
|
44
|
Automated, patient-interactive, spinal cord stimulator adjustment: a randomized controlled trial.
|
Neurosurgery
|
2003
|
0.77
|
|
45
|
Methodologic issues in terminating enrollment of a subgroup of patients in a multicenter randomized trial.
|
Clin Trials
|
2004
|
0.77
|
|
46
|
Improving the quality of clinical trials in surgery.
|
J Thorac Cardiovasc Surg
|
2006
|
0.75
|
|
47
|
Spinal cord stimulator adjustment to maximize implanted battery longevity: a randomized, controlled trial using a computerized, patient-interactive programmer.
|
Neuromodulation
|
2004
|
0.75
|